BioCardia (BCDA) Short Interest Ratio & Short Volume $1.88 -0.07 (-3.83%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioCardia Short Interest DataBioCardia (BCDA) has a short interest of 137,000 shares, representing 3.72% of the float (the number of shares available for trading by the public). This marks a 243.36% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.8, indicating that it would take 1.8 days of the average trading volume of 288,652 shares to cover all short positions.Current Short Interest137,000 sharesPrevious Short Interest39,900 sharesChange Vs. Previous Month+243.36%Dollar Volume Sold Short$430,180.00Short Interest Ratio1.8 Days to CoverLast Record DateApril 30, 2025Outstanding Shares5,178,000 sharesFloat Size3,680,000 sharesShort Percent of Float3.72%Today's Trading Volume42,286 sharesAverage Trading Volume288,652 sharesToday's Volume Vs. Average15% Short Selling BioCardia? Sign up to receive the latest short interest report for BioCardia and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBCDA Short Interest Over TimeBCDA Days to Cover Over TimeBCDA Percentage of Float Shorted Over Time BioCardia Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025137,000 shares $430,180.00 +243.4%3.7%1.8 $3.14 4/15/202539,900 shares $81,795.00 -24.4%1.1%0.6 $2.05 3/31/202552,800 shares $134,112.00 +5.6%1.4%0.8 $2.54 3/15/202550,000 shares $130,000.00 +111.0%1.4%1 $2.60 2/28/202523,700 shares $47,637.00 -57.8%0.7%0.5 $2.01 2/15/202556,200 shares $159,608.00 +4.7%1.5%1.2 $2.84 1/31/202553,700 shares $132,639.00 +67.3%1.4%1.1 $2.47 1/15/202532,100 shares $71,262.00 -36.3%0.8%0.6 $2.22 12/31/202450,400 shares $109,872.00 -39.6%1.3%1 $2.18 12/15/202483,400 shares $173,472.00 -19.5%2.2%1.5 $2.08 Get the Latest News and Ratings for BCDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioCardia and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024103,600 shares $236,208.00 -5.4%2.9%1 $2.28 11/15/2024109,500 shares $202,575.00 +26.9%3.1%0.1 $1.85 10/31/202486,300 shares $201,079.00 +72.6%3.2%0.1 $2.33 10/15/202450,000 shares $122,000.00 -62.2%1.8%0.1 $2.44 9/30/2024132,100 shares $412,152.00 -12.6%4.8%0.2 $3.12 9/15/2024151,200 shares $449,064.00 -91.7%6.4%0.2 $2.97 8/31/20241,830,000 shares $5.58 million +2,719.7%84.3%2.3 $3.05 8/15/202464,900 shares $188,210.00 +104.1%4.3%0.4 $2.90 7/31/202431,800 shares $95,718.00 +8.2%2.5%0.2 $3.01 7/15/202429,400 shares $104,076.00 -38.8%2.3%0.2 $3.54 6/30/202448,000 shares $142,560.00 -37.7%3.7%0.4 $2.97 6/15/202477,100 shares $262,911.00 +267.1%6.0%0.6 $3.41 5/31/202421,000 shares $97,020.00 -91.1%1.6%0.2 $4.62 5/15/2024235,400 shares $92,041.40 -10.4%N/A0.7 $0.39 4/30/2024262,800 shares $101,729.88 -3.1%N/A0.8 $0.39 4/15/2024271,200 shares $100,994.88 -49.4%N/A0.8 $0.37 3/31/2024535,900 shares $218,111.30 -46.9%N/A1.4 $0.41 3/15/20241,010,000 shares $393,900.00 +927.5%6.2%2.7 $0.39 2/29/202498,300 shares $54,065.00 -67.0%0.7%0.3 $0.55 2/15/2024297,600 shares $127,968.00 +84.2%2.5%1 $0.43 1/31/2024161,600 shares $73,237.12 +22.8%1.3%0.1 $0.45 1/15/2024131,600 shares $85,329.44 -39.2%1.1%0 $0.65 12/31/2023216,600 shares $143,865.72 -31.8%1.8%0.1 $0.66 12/15/2023317,800 shares $190,997.80 -9.0%2.7%0.1 $0.60 11/30/2023349,100 shares $216,860.92 +132.0%3.5%0.1 $0.62 11/15/2023150,500 shares $142,222.50 +13.4%1.5%0.1 $0.95 10/31/2023132,700 shares $49,404.21 -35.2%1.3%1.2 $0.37 10/15/2023204,900 shares $90,156.00 +9.8%2.1%1.5 $0.44 9/30/2023186,600 shares $80,219.34 +48.1%1.6%1.4 $0.43 9/15/2023126,000 shares $49,770.00 -36.7%1.1%0.9 $0.40Elon just did WHAT!? (Ad)As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.Click here to see how to claim your stake before they launch to avoid missing out. 8/31/2023199,000 shares $155,220.00 +8.0%1.7%1.8 $0.78 8/15/2023184,300 shares $162,147.14 +575.1%1.5%1.9 $0.88 7/31/202327,300 shares $28,119.00 -84.0%0.2%0.3 $1.03 7/15/2023171,000 shares $398,430.00 -14.2%1.4%2.4 $2.33 6/30/2023199,400 shares $532,398.00 -4.3%1.6%5.1 $2.67 6/15/2023208,300 shares $477,007.00 +3.8%1.6%5.6 $2.29 5/31/2023200,600 shares $355,062.00 +1,443.1%1.6%6.9 $1.77 5/15/202313,000 shares $24,050.00 -29.4%0.1%0.5 $1.85 4/30/202318,400 shares $37,904.00 -12.0%0.1%0.9 $2.06 4/15/202320,900 shares $40,964.00 -23.7%0.1%0.9 $1.96 3/31/202327,400 shares $53,430.00 -26.9%0.2%1 $1.95 3/15/202337,500 shares $73,875.00 +4.8%0.3%1.2 $1.97 2/28/202335,800 shares $78,760.00 +96.7%0.3%0.7 $2.20 2/15/202318,200 shares $40,586.00 -56.6%0.1%0.4 $2.23 1/31/202341,900 shares $106,426.00 -4.3%0.3%0.9 $2.54 1/15/202343,800 shares $100,302.00 -15.4%0.4%1 $2.29 12/30/202251,800 shares $108,262.00 -40.6%0.4%1.2 $2.09 12/15/202287,200 shares $149,112.00 +149.1%0.7%2 $1.71 11/30/202235,000 shares $64,750.00 +44.0%0.2%0.8 $1.85 11/15/202224,300 shares $45,684.00 -42.1%0.2%0.5 $1.88 10/31/202242,000 shares $81,900.00 -24.5%0.3%0.7 $1.95 10/15/202255,600 shares $116,204.00 -37.3%0.4%0.9 $2.09 9/30/202288,600 shares $171,884.00 -7.2%0.7%1.4 $1.94 9/15/202295,500 shares $193,865.00 -2.7%0.7%1.6 $2.03 8/31/202298,100 shares $195,219.00 +182.7%0.7%1.4 $1.99 8/15/202234,700 shares $58,296.00 -42.1%0.3%0.7 $1.68 7/31/202259,900 shares $86,855.00 -25.7%0.5%1.2 $1.45 7/15/202280,600 shares $124,930.00 -47.7%0.8%1.2 $1.55 6/30/2022154,200 shares $223,590.00 -29.3%1.6%0.2 $1.45 6/15/2022218,100 shares $307,521.00 -42.2%2.3%0.3 $1.41 5/31/2022377,300 shares $633,864.00 -2.8%2.9%0.6 $1.68 5/15/2022388,200 shares $543,480.00 -38.1%3.0%0.6 $1.40 4/30/2022627,000 shares $965,580.00 -49.8%5.0%0.7 $1.54 4/15/20221,250,000 shares $1.86 million +150.1%10.0%0.7 $1.49 3/31/2022499,900 shares $1.03 million -5.7%4.0%0.4 $2.07 3/15/2022530,100 shares $1.03 million -10.4%4.2%0.4 $1.95 2/28/2022591,700 shares $1.22 million -45.2%4.7%0.4 $2.07 2/15/20221,080,000 shares $2.39 million +425.3%8.5%0.8 $2.21 1/31/2022205,600 shares $380,360.00 -7.3%1.6%0.2 $1.85 1/15/2022221,700 shares $390,192.00 -13.8%1.7%1.5 $1.76 12/31/2021257,300 shares $499,162.00 +57.5%2.0%1.8 $1.94 12/15/2021163,400 shares $281,048.00 -30.9%1.3%1.2 $1.72 11/30/2021236,300 shares $484,415.00 -10.0%1.9%1.7 $2.05 11/15/2021262,600 shares $643,370.00 -10.5%2.1%1.9 $2.45 10/29/2021293,300 shares $821,240.00 +3.8%2.3%2.1 $2.80 10/15/2021282,700 shares $828,311.00 +8.7%2.2%2 $2.93 9/30/2021260,000 shares $816,400.00 +33.2%2.0%1.8 $3.14 9/15/2021195,200 shares $554,368.00 -0.9%1.5%1.4 $2.84 8/31/2021197,000 shares $581,150.00 -34.0%1.6%2.8 $2.95 8/13/2021298,300 shares $924,730.00 +5.3%2.3%4 $3.10Elon just did WHAT!? (Ad)As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.Click here to see how to claim your stake before they launch to avoid missing out. 7/30/2021283,400 shares $940,888.00 -13.8%2.2%3.8 $3.32 7/15/2021328,900 shares $1.11 million -10.7%2.6%4.2 $3.36 6/30/2021368,200 shares $1.46 million +2.1%2.9%4.2 $3.97 6/15/2021360,500 shares $1.60 million -20.0%2.8%3.4 $4.43 5/28/2021450,400 shares $1.84 million +4.9%3.6%4.3 $4.09 5/14/2021429,300 shares $1.43 million +2.0%N/A3.6 $3.32 4/30/2021420,900 shares $1.49 million -0.2%N/A2.6 $3.54 4/15/2021421,900 shares $1.73 million -7.9%N/A1.8 $4.09 3/31/2021458,300 shares $1.82 million +68.4%N/A1.5 $3.98 3/15/2021272,200 shares $1.09 million +25.3%N/A0.5 $4.00 2/26/2021217,300 shares $873,546.00 +0.5%N/A0.1 $4.02 2/12/2021216,200 shares $1.08 million -63.5%N/A0.1 $4.98 1/29/2021591,600 shares $2.48 million -33.8%N/A0.2 $4.20 1/15/2021894,200 shares $3.35 million +49.8%N/A0.2 $3.75 12/31/2020597,100 shares $2.10 million +4,715.3%N/A0.2 $3.52 12/15/202012,400 shares $55,552.00 +9.7%N/A0 $4.48 11/30/202011,300 shares $26,555.00 -6.6%N/A0.2 $2.35 11/15/202012,100 shares $26,257.00 -57.4%N/A0.2 $2.17 10/30/202028,400 shares $58,220.00 +3.7%N/A0.3 $2.05 10/15/202027,400 shares $64,664.00 -9.9%N/A0.3 $2.36 9/30/202030,400 shares $69,008.00 +237.8%N/A0.3 $2.27 9/15/20209,000 shares $21,375.00 -61.9%N/A0 $2.38 BCDA Short Interest - Frequently Asked Questions What is BioCardia's current short interest? Short interest is the volume of BioCardia shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 137,000 shares of BCDA short. 3.72% of BioCardia's shares are currently sold short. Learn More on BioCardia's current short interest. What is a good short interest ratio for BioCardia? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCDA shares currently have a short interest ratio of 2.0. Learn More on BioCardia's short interest ratio. What is a good short interest percentage for BioCardia? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.72% of BioCardia's floating shares are currently sold short. Is BioCardia's short interest increasing or decreasing? BioCardia saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 137,000 shares, an increase of 243.4% from the previous total of 39,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioCardia's float size? BioCardia currently has issued a total of 5,178,000 shares. Some of BioCardia's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioCardia currently has a public float of 3,680,000 shares. How does BioCardia's short interest compare to its competitors? 3.72% of BioCardia's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioCardia: Adverum Biotechnologies, Inc. (10.67%), Gain Therapeutics, Inc. (1.06%), Skye Bioscience, Inc. (18.48%), Precision BioSciences, Inc. (22.45%), Ikena Oncology, Inc. (0.93%), Karyopharm Therapeutics Inc. (25.06%), Renovaro Inc. (6.45%), Outlook Therapeutics, Inc. (17.45%), PepGen Inc. (8.24%), Shattuck Labs, Inc. (3.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short BioCardia stock? Short selling BCDA is an investing strategy that aims to generate trading profit from BioCardia as its price is falling. BCDA shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioCardia? A short squeeze for BioCardia occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCDA, which in turn drives the price of the stock up even further. How often is BioCardia's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCDA, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Adverum Biotechnologies Short Interest Gain Therapeutics Short Interest Skye Bioscience Short Interest Precision BioSciences Short Interest Ikena Oncology Short Interest Karyopharm Therapeutics Short Interest Renovaro Short Interest Outlook Therapeutics Short Interest PepGen Short Interest Shattuck Labs Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCDA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCardia, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCardia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCDA Stock Free BCDA Stock Alerts